An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) (REVIVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01483898
Recruitment Status : Completed
First Posted : December 2, 2011
Last Update Posted : June 6, 2017
Information provided by (Responsible Party):
Vericel Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2014
  Study Completion Date : April 2014
  Certification/Extension First Submitted : June 23, 2016